Presentation is loading. Please wait.

Presentation is loading. Please wait.

Cutaneous squamous cell carcinoma progression during imiquimod treatment  Emi Dika, MD, Pier Alessandro Fanti, MD, Martina Lambertini, MD, Federica Scarfì,

Published byIldikó Alíz Gál Modified over 6 years ago

Similar presentations

Presentation on theme: "Cutaneous squamous cell carcinoma progression during imiquimod treatment  Emi Dika, MD, Pier Alessandro Fanti, MD, Martina Lambertini, MD, Federica Scarfì,"— Presentation transcript:

1 Cutaneous squamous cell carcinoma progression during imiquimod treatment 
Emi Dika, MD, Pier Alessandro Fanti, MD, Martina Lambertini, MD, Federica Scarfì, MD, Giulia Maria Ravaioli, MD, Giulia Veronesi, MD, Carlotta Baraldi, MD, Alba Guglielmo, MD, Annalisa Patrizi, MD  Journal of the American Academy of Dermatology  Volume 79, Issue 1, Pages e11-e12 (July 2018) DOI: /j.jaad Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions

2 Fig 1 Clinical presentation of patient with cutaneous squamous cell carcinoma of the head and neck and multiple actinic keratoses. A, Histologically proven in situ squamous cell carcinoma and multiple actinic keratoses of the left cheek before treatment with topical imiquimod 5% cream. B, Almost complete healing was observed after 14 weeks treatment. C, Ten months after completion of treatment, a histologically proven poorly differentiated squamous cell carcinoma invading the deep dermis was diagnosed. Journal of the American Academy of Dermatology  , e11-e12DOI: ( /j.jaad ) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions

Download ppt "Cutaneous squamous cell carcinoma progression during imiquimod treatment  Emi Dika, MD, Pier Alessandro Fanti, MD, Martina Lambertini, MD, Federica Scarfì,"

Similar presentations

Use of the diagonal mattress suture to prevent dog-ear formation

Use of the diagonal mattress suture to prevent dog-ear formation
Steven Q. Wang, MD, Leonard H. Goldberg, MD, FRCP 

Steven Q. Wang, MD, Leonard H. Goldberg, MD, FRCP 
Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ on the trunk and extremities with ablative fractional laser-assisted.

Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ on the trunk and extremities with ablative fractional laser-assisted.
CD47 expression for in situ and invasive cutaneous epithelial lesions

CD47 expression for in situ and invasive cutaneous epithelial lesions
Facial adenocarcinoma treated with intra-arterial chemotherapy

Facial adenocarcinoma treated with intra-arterial chemotherapy
Striking leflunomide efficacy against refractory cutaneous sarcoidosis

Striking leflunomide efficacy against refractory cutaneous sarcoidosis
Yul W. Yang, MD, PhD, David J. DiCaudo, MD 

Yul W. Yang, MD, PhD, David J. DiCaudo, MD 
Viral M. Patel, MD, Marc Z. Handler, MD, Robert A

Viral M. Patel, MD, Marc Z. Handler, MD, Robert A
Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients  Lucy Y. Liu, BA, Brittany.

Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients  Lucy Y. Liu, BA, Brittany.
Allison Hanlon, MD, PhD, June Kim, MD, David J. Leffell, MD 

Allison Hanlon, MD, PhD, June Kim, MD, David J. Leffell, MD 
Diffuse hyperpigmented plaques as cutaneous manifestation of multicentric Castleman disease and treatment with thalidomide: Report of three cases  Xiaoqing.

Diffuse hyperpigmented plaques as cutaneous manifestation of multicentric Castleman disease and treatment with thalidomide: Report of three cases  Xiaoqing.
Image registration of sequential transparent photographs to localize and detect new versus recurrent tumors in dermatologic and Mohs micrographic surgery 

Image registration of sequential transparent photographs to localize and detect new versus recurrent tumors in dermatologic and Mohs micrographic surgery 
Baldness reversed by chemotherapy

Baldness reversed by chemotherapy
Megan Wood, MD, Tom Raisanen, MD, Ingrid Polcari, MD 

Megan Wood, MD, Tom Raisanen, MD, Ingrid Polcari, MD 
Focal nail dystrophy in a cutaneous nerve distribution after trauma

Focal nail dystrophy in a cutaneous nerve distribution after trauma
Array of cutaneous adverse effects associated with sorafenib

Array of cutaneous adverse effects associated with sorafenib
Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD 

Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD 
Exploring the relationship between natural killer cells and cutaneous squamous cell carcinoma development  Muneeb Ilyas, BSc, Collin M. Costello, BS,

Exploring the relationship between natural killer cells and cutaneous squamous cell carcinoma development  Muneeb Ilyas, BSc, Collin M. Costello, BS,
María Jesús Suárez Valladares, MD, Manuel Ángel Rodríguez Prieto, MD 

María Jesús Suárez Valladares, MD, Manuel Ángel Rodríguez Prieto, MD 
Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: A phase I to II, open-label trial in 17 patients  Noël Emile Célestin.

Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: A phase I to II, open-label trial in 17 patients  Noël Emile Célestin.

Similar presentations

Ads by Google